212631-61-3
212631-61-3
Chemical Structure
PD 198306
- CAS No.: 212631-61-3
- Formula:C18H16F3IN2O2
- Molecular Weight:476.23
IUPAC Name: N-(cyclopropylmethoxy)-3,4,5-trifluoro-2-((4-iodo-2-methylphenyl)amino)benzamide
InChIKey: UHAXDAKQGVISBZ-UHFFFAOYSA-N
SMILES: O=C(NOCC1CC1)C(C=C(F)C(F)=C2F)=C2NC3=C(C=C(I)C=C3)C
Biological Activity: PD 198306 is a selective MAPK/ERK-kinase (MEK) inhibitor. PD 198306 results in an observable reduction in the Streptozocin induced increase in the level of active ERK1 and 2. Antihyperalgesic effects[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
PD 198306 | 99.75% | PD 198306 is a selective MAPK/ERK-kinase (MEK) inhibitor. PD 198306 results in an observable reduction in the Streptozocin induced increase in the level of active ERK1 and 2. Antihyperalgesic effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
PD 198306 (Standard) | PD 198306 (Standard) is the analytical standard of PD 198306 (HY-107620). This product is intended for research and analytical applications. PD 198306 is a selective MAPK/ERK-Kinase (MEK) inhibitor. PD 198306 results in an observable reduction in the Streptozocin induced increase in the level of active ERK1 and 2. Antihyperalgesic effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
